Abstract
A meta-analysis found oral anticoagulant (OAC) monotherapy provided efficacy comparable to OAC plus single antiplatelet therapy-with lower bleeding risk.
MeSH terms
-
Atrial Fibrillation / drug therapy*
-
Coronary Artery Disease / complications*
-
Coronary Artery Disease / drug therapy
-
Factor Xa Inhibitors / pharmacology*
-
Factor Xa Inhibitors / standards
-
Humans
-
Risk Factors
-
Treatment Outcome